Aug 17, 2009 05:30 PM | 3
Gadget makers have for decades relied on ever-shrinking microchips to make more portable, yet more powerful, devices. But as the components used to make these chips become smaller, with widths measured in dozens rather than hundreds of nanometers, they become increasingly more difficult to assemble.
Since microchips are the engines performing the logic functions that make computers, cell phones and countless other electronic gadgets run, technology makers like IBM have been looking to pack more transistors closer together in smaller spaces.
Now comes a potential solution. IBM Research and the California Institute of Technology researchers say they may have found a way to control the placement of silicon nanowires, carbon nanotubes and other tiny components on microchips through the use of synthetic DNA and tiny lithographic templates. The scientists used the DNA molecules to function as scaffolding, to help deposit millions of nanosize particles in precise patterns, according to a study to be published in the September issue of Nature Nanotechnology . ( Scientific American is part of the Nature Publishing Group). The templates help the nanoparticles hold their shape.
When the DNA is folded into certain origami-like structures, it might even possible to place components six nanometers apart (even thinner than a cell membrane), whereas conventional semiconductor fabrication techniques are struggling to reach placement closer than 22 nanometers (a number thought to be out of reach just a few years ago).
DNA origami is created by using hundreds of short DNA strands (also called "staples") to fold much longer genetic ribbons into nanoscale shapes and patterns. Some researchers think that DNA origami proves microscopic material can be controlled to form specific objects, including smaller circuits.
Technology makers are looking for ways to keep pace with Moore's law, an observation by Intel co-founder Gordon Moore in 1965 that the number of transistors placed on an integrated circuit doubles every two years. The cost to continually shrink electronic components to improve performance is a limiting factor in keeping pace with Moore's law and "a concern across the semiconductor industry," Spike Narayan, manager for science and technology at IBM's Almaden Research Center in San Jose, Calif., said in a prepared statement. IBM seeks better ways to assemble microchip components at the nanoscale without the need to replace existing chip-making technology.
There is a downside to this in that smaller components create more complexity and require some way of dissipating heat before it destroys the surrounding circuitry.
Of course, IBM and other tech companies have some time to work this out: the company says it will be at least a decade before its DNA microchips are ready for the market, according to the Guardian UK .
Image of triangular DNA origami adhering to a template © IBM
Tags:
IBM,
origami,
Moore's law,
DNA
More News Blog:
Next: Marijuana growers started California wildfires
Previous: Bountiful bikes: Can a share program get more people cycling around cities?
Deadline: Jul 25 2013
Reward: Varies
This challenge provides an opportunity for Solvers to build a web-based or mobile “app” to explore data relationships in scholarly conte
Deadline: Aug 31 2013
Reward: $100,000 USD
The Geoffrey Beene Foundation Alzheimer’s Initiative (GBFAI) is launching the 2013 Geoffrey Beene Global NeuroDiscovery Challenge whose
Powered By: 
3 Comments
Add CommentWell obviously Moore's law is going to have a limit or in a hundred years there'd be more transistors packed on to an IC chip than there are atoms in the universe. Trying to keep pace is silly.
Reply | Report Abuse | Link to thisAt some point, the performance boosts are going to start having to come from bringing the rest of the components up to speed...
I'm putting my money on quantum computing. Even if it takes longer, it has a lot more potential than conventional semi-conductor based transistors.
Reply | Report Abuse | Link to thisI wonder if this chips could be used to medical purposes in such diseases as schizophrenia , bipolar disorder and schizoaffective disorder. If somedody could answer me i would appreciate it. :)
Reply | Report Abuse | Link to this